These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 10503275)
1. Combination antimicrobial therapy of acute Burkholderia pseudomallei infection in a mouse model. Ulett GC; Norton RE; Hirst RG Pathology; 1999 Aug; 31(3):264-7. PubMed ID: 10503275 [TBL] [Abstract][Full Text] [Related]
2. Activity of tigecycline in the treatment of acute Burkholderia pseudomallei infection in a murine model. Feterl M; Govan B; Engler C; Norton R; Ketheesan N Int J Antimicrob Agents; 2006 Nov; 28(5):460-4. PubMed ID: 17046208 [TBL] [Abstract][Full Text] [Related]
3. A comparison of antibiotic regimens in the treatment of acute melioidosis in a mouse model. Ulett GC; Hirst R; Bowden B; Powell K; Norton R J Antimicrob Chemother; 2003 Jan; 51(1):77-81. PubMed ID: 12493790 [TBL] [Abstract][Full Text] [Related]
4. Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Jenney AW; Lum G; Fisher DA; Currie BJ Int J Antimicrob Agents; 2001 Feb; 17(2):109-13. PubMed ID: 11165114 [TBL] [Abstract][Full Text] [Related]
5. Case report: recovery from persistent septicemic melioidosis. Inglis TJ; Golledge CL; Clair A; Harvey J Am J Trop Med Hyg; 2001 Jul; 65(1):76-82. PubMed ID: 11504412 [TBL] [Abstract][Full Text] [Related]
6. Current antimicrobial susceptibility of first-episode melioidosis Burkholderia pseudomallei isolates from the Northern Territory, Australia. Crowe A; McMahon N; Currie BJ; Baird RW Int J Antimicrob Agents; 2014 Aug; 44(2):160-2. PubMed ID: 24924662 [TBL] [Abstract][Full Text] [Related]
7. Pulmonary Delivery of Ceftazidime for the Treatment of Melioidosis in a Murine Model. Ruiz SI; Bowen LE; Bailey MM; Berkland C Mol Pharm; 2018 Mar; 15(3):1371-1376. PubMed ID: 29363975 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial susceptibility of Burkholderia pseudomallei isolates in Northern Vietnam. Nhung PH; Van VH; Anh NQ; Phuong DM J Glob Antimicrob Resist; 2019 Sep; 18():34-36. PubMed ID: 30685463 [TBL] [Abstract][Full Text] [Related]
9. Immunotherapy markedly increases the effectiveness of antimicrobial therapy for treatment of Burkholderia pseudomallei infection. Propst KL; Troyer RM; Kellihan LM; Schweizer HP; Dow SW Antimicrob Agents Chemother; 2010 May; 54(5):1785-92. PubMed ID: 20176901 [TBL] [Abstract][Full Text] [Related]
10. Melioidosis presenting as urinary tract infection in a previously healthy tourist. Carlson P; Seppänen M Scand J Infect Dis; 2000; 32(1):92-3. PubMed ID: 10716086 [TBL] [Abstract][Full Text] [Related]
11. Farnesol increases the susceptibility of Burkholderia pseudomallei biofilm to antimicrobials used to treat melioidosis. Castelo-Branco DS; Riello GB; Vasconcelos DC; Guedes GM; Serpa R; Bandeira TJ; Monteiro AJ; Cordeiro RA; Rocha MF; Sidrim JJ; Brilhante RS J Appl Microbiol; 2016 Mar; 120(3):600-6. PubMed ID: 26669506 [TBL] [Abstract][Full Text] [Related]
12. Burkholderia pseudomallei: the unbeatable foe? Leelarasamee A Southeast Asian J Trop Med Public Health; 1998 Jun; 29(2):410-5. PubMed ID: 9886137 [TBL] [Abstract][Full Text] [Related]
13. A case report of Tubo-ovarian abscess caused by Burkholderia pseudomallei. Nernsai P; Sophonsritsuk A; Lertvikool S; Jinawath A; Chitasombat MN BMC Infect Dis; 2018 Feb; 18(1):73. PubMed ID: 29422033 [TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, controlled study of cefoperazone-sulbactam plus cotrimoxazole versus ceftazidime plus cotrimoxazole for the treatment of severe melioidosis. Chetchotisakd P; Porramatikul S; Mootsikapun P; Anunnatsiri S; Thinkhamrop B Clin Infect Dis; 2001 Jul; 33(1):29-34. PubMed ID: 11389491 [TBL] [Abstract][Full Text] [Related]
16. Susceptibility of Clinical Isolates of Sengyee S; Saiprom N; Paksanont S; Limmathurotsakul D; Wuthiekanun V; Chantratita N Am J Trop Med Hyg; 2017 Jul; 97(1):62-67. PubMed ID: 28719324 [No Abstract] [Full Text] [Related]
17. Multicenter prospective randomized trial comparing ceftazidime plus co-trimoxazole with chloramphenicol plus doxycycline and co-trimoxazole for treatment of severe melioidosis. Sookpranee M; Boonma P; Susaengrat W; Bhuripanyo K; Punyagupta S Antimicrob Agents Chemother; 1992 Jan; 36(1):158-62. PubMed ID: 1590682 [TBL] [Abstract][Full Text] [Related]
18. Experimental Persistent Infection of BALB/c Mice with Small-Colony Variants of Burkholderia pseudomallei Leads to Concurrent Upregulation of PD-1 on T Cells and Skewed Th1 and Th17 Responses. See JX; Samudi C; Saeidi A; Menon N; Choh LC; Vadivelu J; Shankar EM PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004503. PubMed ID: 26974441 [TBL] [Abstract][Full Text] [Related]
19. Comparative virulence of three different strains of Burkholderia pseudomallei in an aerosol non-human primate model. Trevino SR; Dankmeyer JL; Fetterer DP; Klimko CP; Raymond JLW; Moreau AM; Soffler C; Waag DM; Worsham PL; Amemiya K; Ruiz SI; Cote CK; Krakauer T PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009125. PubMed ID: 33571211 [TBL] [Abstract][Full Text] [Related]
20. Highly resistant Burkholderia pseudomallei small colony variants isolated in vitro and in experimental melioidosis. Häussler S; Rohde M; Steinmetz I Med Microbiol Immunol; 1999 Nov; 188(2):91-7. PubMed ID: 10753061 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]